Gradient Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Gradient Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-450	Closed	-$40.2K	–	1860
2023 Q4	$40.2K	Sell	450 -23	-5%	-$1.71K	﹤0.01%	588
2023 Q3	$34.5K	Hold	473	–	–	﹤0.01%	584
2023 Q2	$39.4K	Sell	473 -200	-30%	-$16.7K	﹤0.01%	551
2023 Q1	$51.3K	Hold	673	–	–	﹤0.01%	492
2022 Q4	$55.9K	Hold	673	–	–	﹤0.01%	479
2022 Q3	$53K	Buy	673 +23	+4%	+$1.94K	﹤0.01%	476
2022 Q2	$48K	Hold	650	–	–	﹤0.01%	483
2022 Q1	$58K	Hold	650	–	–	﹤0.01%	450
2021 Q4	$73K	Hold	650	–	–	﹤0.01%	414
2021 Q3	$82K	Hold	650	–	–	﹤0.01%	400
2021 Q2	$88K	Sell	650 -150	-19%	-$19.7K	﹤0.01%	385
2021 Q1	$109K	Hold	800	–	–	﹤0.01%	353
2020 Q4	$89K	Hold	800	–	–	﹤0.01%	329
2020 Q3	$89K	Hold	800	–	–	﹤0.01%	330
2020 Q2	$90K	Buy	800 +199	+33%	+$19.6K	﹤0.01%	313
2020 Q1	$47K	Buy	601 +301	+100%	+$26.7K	﹤0.01%	357
2019 Q4	$29K	Hold	300	–	–	﹤0.01%	507
2019 Q3	$23K	Hold	300	–	–	﹤0.01%	511
2019 Q2	$26K	Hold	300	–	–	﹤0.01%	476
2019 Q1	$27K	Buy	+300	New	+$25.5K	﹤0.01%	410
2018 Q2	–	Sell	-188	Closed	-$16K	–	1156
2018 Q1	$16K	Sell	188 -2,500	-93%	-$228K	﹤0.01%	533
2017 Q4	$228K	Buy	+2,688	New	+$225K	0.01%	239
2017 Q3	–	Sell	-11,700	Closed	-$903K	–	727
2017 Q2	$903K	Sell	11,700 -1,519	-11%	-$108K	0.06%	99
2017 Q1	$917K	Sell	13,219 -1,081	-8%	-$72.6K	0.07%	104
2016 Q4	$846K	Buy	+14,300	New	+$883K	0.07%	104

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Gradient Investments's XBI Position: Q1 2024 in Review

Gradient Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 450 shares — an estimated $40.2K sold.

Gradient Investments first reported a position in XBI in Q4 2016 and held it in 25 quarters. The position peaked at $917K in Q1 2017. 781 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Gradient Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Gradient Investments sold 450 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $40.2K.
Gradient Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 25 quarters.
Gradient Investments's State Street SPDR S&P Biotech ETF position peaked at $917K in Q1 2017.
781 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.